TrialBMJ (Clinical research ed.)2018

Mirtazapine added to SSRIs or SNRIs for treatment resistant depression in primary care: phase III randomised placebo controlled trial (MIR).

David S Kessler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.